HomeEVOK • NASDAQ
add
Evoke Pharma Inc
Previous close
$5.12
Day range
$4.87 - $5.23
Year range
$1.94 - $9.88
Market cap
7.98M USD
Avg Volume
26.93K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | 3.75M | 47.06% |
Operating expense | 5.14M | 37.76% |
Net income | -1.57M | -23.97% |
Net profit margin | -41.87 | 15.70% |
Earnings per share | -0.62 | 33.33% |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 12.06M | 31.39% |
Total assets | 16.06M | 32.33% |
Total liabilities | 11.69M | 23.38% |
Total equity | 4.37M | — |
Shares outstanding | 2.09M | — |
Price to book | 2.37 | — |
Return on assets | -24.03% | — |
Return on capital | -38.04% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -1.57M | -23.97% |
Cash from operations | -565.02K | 31.15% |
Cash from investing | — | — |
Cash from financing | 0.00 | -100.00% |
Net change in cash | -565.02K | -7.64% |
Free cash flow | -46.01K | 88.74% |
About
Founded
2007
Headquarters
Website
Employees
3
